Stock 2666 GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Genertec Universal Medical Group Company Limited

Equities

2666

HK0000255361

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:16 02/05/2024 pm IST 		5-day change 1st Jan Change
4.85 HKD +2.75% Intraday chart for Genertec Universal Medical Group Company Limited +3.19% +8.02%
17/04 Genertec Universal Medical Unit to Raise Up to 2 Billion Yuan from Bond Issue MT
27/03 Genertec Universal Medical Group Company Limited Announces Final Dividend for the Year Ended 31 December 2023 CI

Strengths

  • The company returns high margins, thereby supporting business profitability.
  • Its low valuation, with P/E ratio at 4.65 and 3.93 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Corporate Financial Services

1st Jan change Capi. Investor Rating ESG Refinitiv
GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED Stock Genertec Universal Medical Group Company Limited
+8.02% 1.14B -
INDIAN RAILWAY FINANCE CORPORATION LIMITED Stock Indian Railway Finance Corporation Limited
+59.94% 24.62B - -
FTAI AVIATION LTD. Stock FTAI Aviation Ltd.
+57.76% 7.34B
D
BOC AVIATION LIMITED Stock BOC Aviation Limited
+4.52% 5.54B
C
TOKYO CENTURY CORPORATION Stock Tokyo Century Corporation
+2.52% 4.91B
C+
GATX CORPORATION Stock GATX Corporation
+5.09% 4.42B
C+
QNB FINANS FINANSAL KIRALAMA Stock QNB Finans Finansal Kiralama
+37.83% 4.37B - -
CHINA DEVELOPMENT BANK FINANCIAL LEASING CO., LTD. Stock China Development Bank Financial Leasing Co., Ltd.
+51.08% 3.33B -
C+
FUYO GENERAL LEASE CO., LTD. Stock Fuyo General Lease Co., Ltd.
+11.92% 2.62B -
MIZUHO LEASING COMPANY, LIMITED Stock Mizuho Leasing Company, Limited
+16.22% 1.74B -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2666 Stock
  4. Ratings Genertec Universal Medical Group Company Limited